BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

32 related articles for article (PubMed ID: 16275089)

  • 21. New erythromycins.
    Wynn RL
    Gen Dent; 1996; 44(4):304-7. PubMed ID: 8957824
    [No Abstract]   [Full Text] [Related]  

  • 22. Chemistry of six-membered cyclic oxime ethers. Application in the synthesis of bioactive compounds.
    Sukhorukov AY; Ioffe SL
    Chem Rev; 2011 Aug; 111(8):5004-41. PubMed ID: 21434602
    [No Abstract]   [Full Text] [Related]  

  • 23. A Review of Biologically Active Oxime Ethers.
    Kosmalski T; Kupczyk D; Baumgart S; Paprocka R; StudziƄska R
    Molecules; 2023 Jun; 28(13):. PubMed ID: 37446703
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Fundamental Role of Oxime and Oxime Ether Moieties in Improving the Physicochemical and Anticancer Properties of Structurally Diverse Scaffolds.
    Fotie J; Matherne CM; Mather JB; Wroblewski JE; Johnson K; Boudreaux LG; Perez AA
    Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069175
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Highlights of semi-synthetic developments from erythromycin A.
    Wu YJ
    Curr Pharm Des; 2000 Jan; 6(2):181-223. PubMed ID: 10637376
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New directions for macrolide antibiotics: structural modifications and in vitro activity.
    Kirst HA; Sides GD
    Antimicrob Agents Chemother; 1989 Sep; 33(9):1413-8. PubMed ID: 2684004
    [No Abstract]   [Full Text] [Related]  

  • 27. Design, synthesis, and anti-Helicobacter pylori activity of erythromycin A (E)-9-oxime ether derivatives.
    Nam G; Kang TW; Shin JH; Choi KI
    Bioorg Med Chem Lett; 2006 Feb; 16(3):569-72. PubMed ID: 16275089
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Antibiotic resistance in Helicobacter pylori and molecular methods for the detection of resistance].
    Demiray E; Yilmaz O
    Mikrobiyol Bul; 2005 Jul; 39(3):399-408. PubMed ID: 16358500
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Helicobacter pylori treatment: is sequential or quadruple therapy the answer?
    Vakil N
    Rev Gastroenterol Disord; 2008; 8(2):77-82. PubMed ID: 18641590
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of Helicobacter pylori infection.
    Cavallaro LG; Egan B; O'Morain C; Di Mario F
    Helicobacter; 2006 Oct; 11 Suppl 1():36-9. PubMed ID: 16925610
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Advance in synthesis of ketolides, a new class of erythromycin derivatives].
    Lei PS; Xu P; Liu L
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Aug; 26(4):467-73. PubMed ID: 15379279
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Prospect of the development of new bactericidal drugs against Helicobacter pylori for eradication therapy].
    Kamiya S; Taguchi H
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():751-5. PubMed ID: 11979883
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.